Press Release-Medical Radiation Shielding Market to Reach USD 3.27 Billion by 2035

According to analysts at Vantage Market Research, the Global Medical Radiation Shielding Market size is worth USD 1.6 Billion in 2024 and is projected to reach USD 3.27 Billion by 2035, growing at a CAGR (Compound Annual Growth Rate) of 6.7% from 2025 to 2035. Key trends of market include growing adoption of lead-free shielding, increasing demand for mobile radiation shielding, AI integration in radiation monitoring, rising hospital expansions, stricter safety regulations, and advancements in composite shielding materials.

Market Overview

The growing use of nuclear medicine and radiotherapy for diagnosing and treating cancer is significantly driving the demand for Medical Radiation Shielding Market. With cancer cases projected to increase to approximately 30 million by 2040, the need for radiation-based treatments is set to rise. Developing regions such as Africa, Asia, and Central & South America account for over 60% of new cancer cases and 70% of global cancer deaths, highlighting the critical role of radiation therapy in these areas. According to the World Nuclear Association, over 40 million nuclear medicine procedures are performed annually, with radioisotope demand increasing by 5% per year. Currently, nearly 10,000 hospitals worldwide utilize radioisotopes, and in the U.S. alone, more than 20 million nuclear medicine procedures are conducted each year.

Rising healthcare investments in developing countries such as China, India, Brazil, and Mexico are improving access to quality medical services, thereby fueling demand for Medical Radiation Shielding market. The increasing incidence of cancer in these regions is further accelerating the adoption of oncology-related technologies. A surge in per-capita healthcare spending is also driving demand for cost-effective healthcare solutions, including radiation shielding for diagnostic and therapeutic applications.

Marshield Introduced Plasti-Shield, A Neutron Shielding Material

• In April 2024, MarShield introduced Plasti-Shield, a neutron shielding material composed of boron-filled polyethylene. Designed for cost efficiency and lightweight application, this solution effectively absorbs and attenuates neutron radiation. It is widely utilized across various industries, including healthcare, cancer treatment centers, diagnostic facilities, and hospitals

Key Takeaways from the Report

• North America dominated the market with 36.5% of market share in 2024. Market is driven by the increasing adoption of advanced cancer treatments and the rising prevalence of chronic diseases
• Based on the Product Type, the X-ray Shields category accounted for significant market share of 51.5% in 2024. X-Ray are essential for radiation protection in medical imaging
• In 2024, by Material, Lead-based Shielding dominated the market with significant market share of 53.2%. The widespread adoption of X-rays, CT scans, and radiation therapy devices in healthcare settings continues to drive demand for lead shielding solutions as an essential protective measure.
• By Application, Diagnostics dominated the      market with significant market share of 51.5% in 2024. The rising prevalence of chronic illnesses such as cancer and cardiovascular diseases, along with the aging global population, is driving increased demand for diagnostics segment
• In 2024, by End-use, Hospitals & Clinics dominated the market with significant market share of 54.5%. The segment is driven by their high demand for radiation protection solutions

Top Companies

• NELCO
• MAVIG GmbH
• Radiation Protection Products Inc.
• Veritas Medical Solutions
• VacuTec Meßtechnik GmbH
• Nuclear Shields B.V.
• ETS-Lindgren
• Gaven Industries
• MarShield
• Amray Group

Report Coverage

Our market research reports provide comprehensive insights that are essential for strategic decision-making. We cover all key aspects of the market, including dynamics such as drivers, restraints, opportunities, and challenges, alongside the latest industry trends. Our analysis includes an in-depth technology roadmap, product life cycle evaluation, and PESTLE analysis, ensuring a thorough understanding of the market environment. We also assess GDP growth outlooks, examine regional market landscapes, and evaluate the impact of major events like the COVID-19 pandemic. Additionally, our reports feature a detailed competitive landscape, including company market shares and profiles, providing actionable intelligence to empower your business strategies.

Latest News

Researchers at the London Health Sciences Centre Research Institute (LHSCRI) became the first in Canada to treat a patient with neuroendocrine tumors (NETs)

• In October 2024, Researchers at the London Health Sciences Centre Research Institute (LHSCRI) became the first in Canada to treat a patient with neuroendocrine tumors (NETs) using actinium-225 DOTATATE. This innovative therapy, classified under theranostics, combines advanced diagnostic imaging with radioisotopes to precisely locate and eliminate tumors through targeted radioactive energy

About Vantage Market Research:

We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies. The company provides high quality data and market research services. The company serves various enterprises and clients in a wide variety of industries. The company offers detailed reports on multiple industries including Chemical Materials and Energy, Food and Beverages, Healthcare Technology, etc. The company’s experienced team of Analysts, Researchers, and Consultants use proprietary data sources and numerous statistical tools and techniques to gather and analyse information.